|
Professional
/ Research Summary
Cataract
and Glaucoma Surgery
Dr. Lin's fields of expertise include glaucoma surgery and lasers,
cataract surgery, and ultrasound biomicroscopy (UBM) imaging. He has
extensive experience with specialized glaucoma procedures, such as
Ahmed valve surgery, endoscopic cyclophotocoagulation (ECP), and selective
laser trabeculoplasty (SLT). |
|
Dr.
Lin's research interests include both clinical and laboratory science.
He is the Principal Investigator at UCSF for a Phase III FDA clinical
trial that is evaluating the safety and efficacy of oral Memantine
for the treatment of progressive glaucoma. The results of this large,
multi-center trial may lead to an entirely new class of medications
for treating this silent, blinding disease. Dr. Lin is also the co-Principal
Investigator for the NIH-sponsored Ocular Hypertension Treatment Study
(OHTS). Recently the major results from this nationwide trial were
released, showing that treatment of those at risk for developing glaucoma
reduced the chance of developing the disease by at least 50%. Additionally,
Dr. Lin has laboratory projects to determine the molecular and cellular
basis for developing glaucoma.
Dr. Lin is an active member in several medical and scientific societies,
including the American Academy of Ophthalmology and the Association
for Research in Vision and Ophthalmology. He serves as an expert for
the Glaucoma Panel of the Academy's Ophthalmic Technology Assessment
Committee (OTAC). He is also a reviewer for the Journal of Glaucoma
and the British Journal of Ophthalmology. |
| |
|
